The telemedicine market is booming, and Teladoc is leading the way. From fresh IPOs to tech giants, we delve into its top three competitors.
After the IPO madness we saw in 2020, what lessons can we utilize in 2021 to build a healthy investment strategy for this year’s IPO market
The race to dominate the telehealth space is heating up, so in this rapidly expanding market, which is a better investment: the first mover or the hot IPO?
The company should reap up to $560 million in gross proceeds from the issue.
One new telemedicine service has been given a boost from a massive stock-market player.